Navigation Links
ShengdaTech to Present at Rodman & Renshaw Annual China Investment Conference in Shanghai

SHANGHAI, Feb. 28, 2011 /PRNewswire-Asia-FirstCall/ -- ShengdaTech, Inc. ("ShengdaTech" or the "Company") (NASDAQ: SDTH), a leading manufacturer of nano-precipitated calcium carbonate ("NPCC") in China, today announced that Mr. Xiangzhi Chen, the Company's chairman and CEO, Ms. Anhui Guo, COO and acting CFO and Mr. A. Carl Mudd, lead independent director, will attend the Rodman & Renshaw Annual China Investment Conference to be held from March 6-8, 2011 in Shanghai.

The date, time, and location of ShengdaTech's presentation at the Conference are as follows:Date:Tuesday, March 8, 2011Time:  

11:30 a.m. Presenter:

Crocker Coulson, President of CCG Investor RelationsLocation:  

Ballroom II, Le Royal Meridien, Shanghai, ChinaA copy of ShengdaTech's investor presentation will be made available online at: on the day it is presented.

The Rodman & Renshaw's 2011 Annual China Investment Conference will feature diverse industry sectors, including Agriculture, Automotive, Cleantech & Energy, Consumer, Education, Healthcare, Industrial, Metals & Mining, and Technology. The conference is expected to attract over 150 public and private companies and more than 1,000 attendees. For more information about the conference and registration, please visit  

Investors who wish to meet with ShengdaTech's management may contact Rodman & Renshaw or ShengdaTech's IR representative in the U.S., Roger Ellis at +1 (310) 954 1332 or

About ShengdaTech, Inc.  ShengdaTech is engaged in the business of manufacturing, marketing, and selling nano-precipitated calcium carbonate ("NPCC") products. The Company converts limestone into NPCC using its proprietary and patent-protected technology. NPCC products are increasingly used in tires, paper, paints, building materials, and other chemical products. In addition to its broad customer base in China, the Company currently exports to Singapore, Thailand, South Korea, Malaysia, India and Latvia. For more information, contact CCG Investor Relations directly or go to ShengdaTech's website at

Contact:Anhui Guo, Chief Operating OfficerShengdaTech, www.shengdatechinc.comCCG Investor RelationsCrocker Coulson, PresidentTel:   +1-646-213-1915 (NY office)Email: www.ccgirasia.comElaine Ketchmere, PartnerTel:   +1-310-954-1345 (LA office)Email:

SOURCE ShengdaTech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. InterMune to Present at Canaccord Adams Conference
2. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
3. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
5. Bionovo to Present at Canaccord Adams Global Growth Conference
6. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
7. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
8. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
9. Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference
10. Duska Therapeutics to Present at Noble Financial Equity M.A.D. MAX Conference on Tuesday, August 19th at 1:30 p.m. PDT
11. Cepheid to Webcast Upcoming Financial Presentations
Post Your Comments:
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology:
(Date:5/12/2016)... , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: ... area for financial services, but it also plays a fundamental ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
Breaking Biology News(10 mins):